NanoInk names pharma expert to board

June 8, 2006 – NanoInk Inc., a company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries, announced the election of Alan Holmer to the company’s board of directors.

Holmer was elected by NanoInk’s current board of directors as the company seeks to add seasoned board members with industry experience. With the addition of Mr. Holmer, the NanoInk Board will now consist of six members.

Holmer, 56, is the former president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), where he spent nearly ten years leading the organization that represents the interests of leading pharmaceutical and biotechnology companies. He also serves as a member of the Presidential Advisory Council on HIV and AIDS and on the Board of Directors of Inspire Pharmaceuticals.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.